• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-09-16

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is intended to improve resolution of low-molecular-weight proteins and peptides that are difficult to separate with conventional Tris-SDS-PAGE. It is suitable for controlled research protein electrophoresis, including denaturing and non-denaturing workflows when compatible sample and running conditions are used, but it is not intended for diagnostic or medical applications.

• Gemini Quaternary Ammonium Compounds: Study Insights

  2026-09-15

  The reference study describes 16 novel gemini quaternary ammonium compounds designed to address limitations associated with conventional disinfectants, including solubility, cytotoxicity, and incomplete activity across microbial classes. Its integrated synthesis, in silico screening, antibacterial, biofilm, antifungal, virucidal, and cytotoxicity evaluation identifies several promising leads, particularly compounds 1 and 12, while also defining important limits for translation.

• Phosbind Acrylamide: Read Phosphorylation in Gels

  2026-09-15

  Phosbind Acrylamide enables antibody-independent phosphorylation analysis by converting phosphate-dependent interactions into SDS-PAGE mobility shifts. This guide explains how to interpret those shifts, design controls, and connect gel-based evidence to causal protein phosphorylation signaling studies.

• NAT1–ENO1–Lactate Axis in Colorectal Cancer

  2026-09-14

  A 2026 MedComm study identifies NAT1 as a metabolic–immune regulator in colorectal cancer, showing that NAT1 restrains ENO1 activity and lactate production while limiting TRAF6-dependent PD-L1 stabilization. Its integrated database, multi-omics, cellular, patient, and mouse-model evidence provides a mechanistic framework for testing lactate-pathway perturbation alongside immune checkpoint blockade.

• Drug Response Assays: Growth Inhibition vs Cell Death

  2026-09-14

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these measurements capture different dimensions of anticancer drug response. The framework supports more informative, time-aware assay design by separating proliferative arrest from actual cell killing.

• Ionic-Liquid Lyotropy in Coil–Bottlebrush Diblocks

  2026-09-13

  This Macromolecules study examines how coil–bottlebrush diblock copolymers self-assemble in coil-selective alkylimidazolium ionic liquids. Despite substantial changes in solvent selectivity across the ionic-liquid series, the observed lyotropic phase behavior depends only weakly on ionic-liquid identity, suggesting broader solvent-selection flexibility for nanostructured polymer materials.

• Letrozole Workflows for Aromatase Research

  2026-09-12

  Build more interpretable breast cancer research assays with Letrozole by separating aromatase target engagement from downstream estrogen receptor effects. This guide combines DMSO-compatible handling, dose–time design, biomarker readouts, and troubleshooting for hormone-responsive models.

• Modified Ethanol Injection for mRNA Delivery

  2026-09-11

  Tang and colleagues adapted a modified ethanol injection method, previously used for siRNA lipoplexes, to prepare and screen mRNA lipoplexes without specialized microfluidic equipment. The study identified DC-1-16/DOPE/PEG-Chol and TC-1-12/DOPE/PEG-Chol formulations with strong cellular expression, while the DC-1-16 formulation also supported protein expression in mouse lungs and spleen and antigen-specific IgG1 responses.

• Gemini QACs: Broad-Spectrum Biocidal Activity

  2026-09-11

  The reference study reports 16 novel gemini quaternary ammonium compounds designed as potential alternatives to conventional disinfectants, with several candidates showing stronger antimicrobial, antifungal, or virucidal performance than octenidine or benzalkonium chloride. Its integrated use of synthesis, membrane-permeation prediction, broad microbiological testing, biofilm assays, and cytotoxicity analysis provides a useful framework for evaluating next-generation antiseptic research compounds.

• GPNMB Model Predicts Immunotherapy Response in ESCC

  2026-09-10

  This reference study identifies circulating soluble GPNMB as a mechanistically active biomarker of PD-1 blockade resistance in esophageal squamous cell carcinoma. By integrating plasma proteomics, CAF-Epi niche features, and clinicopathological variables, the authors develop a multimodal framework that connects tumor–immune biology with clinically scalable response prediction.

• Esflurbiprofen and Fast-Onset Antidepressant Mechanisms

  2026-09-10

  The reference study identifies esflurbiprofen as a candidate fast-onset antidepressant by disrupting the SERT–nNOS complex in the dorsal raphe nucleus. Its combined screening, behavioral, neuroimaging, and mechanistic approach links PDZ-domain targeting to altered serotonergic feedback and improved depression-related phenotypes in mice.

• Ibrexafungerp Activity at Vaginal pH

  2026-09-09

  This study tested ibrexafungerp against 187 clinical Candida isolates under neutral and acidic conditions that model the vaginal environment. Its central finding was that ibrexafungerp retained broad in vitro activity at pH 4.5, including against fluconazole-resistant isolates, supporting pH-aware susceptibility workflows for vulvovaginal candidiasis research.

• Exemestane Workflows for Aromatase Research

  2026-09-09

  Build reproducible aromatase assays with Exemestane by combining concentration-response testing, irreversible-inactivation controls, and estrogen readouts. This workflow connects enzyme biochemistry with breast cancer research while clarifying how steroidal aromatase inhibition differs from receptor-directed endocrine strategies.

• Mycophenolic Acid: Reading Immune Metabolism

  2026-09-08

  Mycophenolic acid is more than a dehydrogenase inhibitor: it is a pathway perturbation tool for interpreting stimulus-specific immune metabolism. This guide shows how standardized whole-blood assays, matrix-aware controls, and orthogonal readouts can distinguish nucleotide limitation from nonspecific cellular suppression.

• Dehydroabietic Acid: From PPAR Signal to Causality

  2026-09-08

  Dehydroabietic acid is a dual PPAR-α/γ agonist with value beyond descriptive metabolic assays. This article shows how to pair receptor pharmacology with adipocyte-targeted CRISPRi to distinguish lipid metabolism regulation from cell-specific causal effects.

8617 records 1/575 page Next 12345 下5页 Last page